Cart
sales@molnova.com
Neoastilbin
CAS No. 54081-47-9
Neoastilbin( —— )
Catalog No. M24527 CAS No. 54081-47-9
Neoastilbin may have antioxidant and anti-inflammatory activities, it shows potent inhibition of lens aldose reductase.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 122 | In Stock |
|
| 5MG | 101 | In Stock |
|
| 10MG | 163 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameNeoastilbin
-
NoteResearch use only, not for human use.
-
Brief DescriptionNeoastilbin may have antioxidant and anti-inflammatory activities, it shows potent inhibition of lens aldose reductase.
-
DescriptionNeoastilbin may have antioxidant and anti-inflammatory activities, it shows potent inhibition of lens aldose reductase.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptorothers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number54081-47-9
-
Formula Weight450.39
-
Molecular FormulaC21H22O11
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC[C@@H]([C@@H]([C@H]([C@H]1O)O)O)O[C@H]1O[C@@H]([C@H](c(cc1)cc(O)c1O)Oc1c2c(O)cc(O)c1)C2=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Antioxidant and Anti-Inflammatory Activities of Phenolic-Enriched Extracts of Smilax glabra.Evid Based Complement Alternat Med. 2014;2014:910438.
molnova catalog
related products
-
7-Geranyloxy-6-metho...
7-O-Geranylscopoletin is a natural coumarin from the root of Atalantia monophylla. Various parts of this plant have been used for folk medicine for several purposes such as the treatment of chronic rheumatism, antispasmodic, paralysis, hemiplegia, and stimulant.
-
β-Endorphin (1-5), (...
β-Endorphin (1-5), (16-31), human
-
Adrenocorticotropic ...
Adrenocorticotropic Hormone (ACTH) (4-10) is an agonist of potent melanocortin(MC4R) receptor.In humans, Adrenocorticotropic Hormone (ACTH) (4-10)?enters the cerebral fluid compartment after intranasal application and leads to a?decrease in total body fat after 6 weeks of continuous treatment.
